Clinical trial Recruiting at 1 site Observational Ages 20 to 75

Evaluating Enhanced Recovery After Surgery for Pituitary Tumor Patients

Official title: To Assess the Impact of the Enhanced Recovery After Surgery (ERAS) Consensus on the Effectiveness and Prognosis of Patients With Endoscopic Pituitary Tumor Surgery

Run by Chang Gung Memorial Hospital · NCT06221020 · Data updated 2026-11-12

This study is testing whether following a special recovery plan after surgery helps people with pituitary tumors heal better and faster.

Quick facts

Study typeObservational
Ages20 Years to 75 Years
SexAll
Enrollment70 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Locations1 site (Kaohsiung City)
StatusRecruiting
StartedDecember 12, 2023
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedAugust 17, 2026
Trial IDNCT06221020 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals clinically diagnosed with pituitary tumors who can provide informed consent.

Probably not a fit

Patients with other malignant tumors, severe infections, or those who are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the effectiveness of Enhanced Recovery After Surgery (ERAS) protocols in patients undergoing surgery for pituitary gland tumors. It focuses on various aspects of the ERAS approach, including pre-operative and post-operative rehabilitation, pain management, and early resumption of activities. By comparing outcomes between patients who follow the ERAS protocol and those who do not, the study seeks to identify which elements of ERAS contribute most significantly to patient recovery and safety. The findings will help enhance medical practices related to pituitary tumor management.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery times and reduced complications for patients undergoing pituitary tumor surgery.

How similar studies have gone: Other studies have shown positive outcomes with ERAS protocols in various surgical contexts, suggesting potential success in this application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of pituitary tumors
* To sign a written informed consent form

Exclusion Criteria:

* Diagnosed with other malignant tumors
* Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area
* Pregnant women
* Coagulation disorders or those taking anticoagulant medication
* Other central nervous system disorders, alcohol addiction, other addictive drugs, or mental illness that may affect clinical assessment
* Deemed unsuitable for surgical treatment or unable to comply with clinical evaluation upon assessment

Where it's running

  • Kaohsiung Chang Gung Memorial Hospital
    Kaohsiung City, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Hung-Chen Wang, MD, PhD — Chang Gung Memorial Hospital
  • Study coordinator: Hung-Chen Wang, MD, PhD
  • Email: m82whc@gmail.com
  • Phone: +886-975056287

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.